SPHK1 and mesothelioma: As shown in Fig. 3A, pretreatment of mesothelioma cell line H2691, but not Met5A, with the inhibitor SPHK-I2 blocked SphK activity as reflected by the measured intracellular levels of S1P generated using LC/MS/MS [30]–[32].